GENERLAC Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Generlac, and when can generic versions of Generlac launch?
Generlac is a drug marketed by Morton Grove and Wockhardt Bio Ag and is included in two NDAs.
The generic ingredient in GENERLAC is lactulose. There are twenty drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Generlac
A generic version of GENERLAC was approved as lactulose by HIKMA on July 3rd, 1995.
Summary for GENERLAC
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 29 |
Clinical Trials: | 1 |
Patent Applications: | 3,643 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for GENERLAC |
Drug Sales Revenues: | Drug sales revenues for GENERLAC |
DailyMed Link: | GENERLAC at DailyMed |
Recent Clinical Trials for GENERLAC
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tampa General Hospital | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for GENERLAC
US Patents and Regulatory Information for GENERLAC
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Morton Grove | GENERLAC | lactulose | SOLUTION;ORAL, RECTAL | 071842-001 | Sep 27, 1988 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wockhardt Bio Ag | GENERLAC | lactulose | SOLUTION;ORAL, RECTAL | 074603-001 | Oct 31, 1996 | AA | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |